Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease

Clinical trial NCT03543540 · COMPLETED

Trial details

NCT number: NCT03543540
Sponsor: ImmusanT, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Celiac Disease Intestinal Disease Malabsorption Syndromes Gastrointestinal Disease Digestive System Diseases Metabolic Disease Coeliac Disease Gluten Sensitivity

Start date: 2018-05-01
Primary completion: 2018-09-10
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.